The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Signature microRNA Expression Profile of Essential Hypertension and Its Novel Link to Human Cytomegalovirus Infection
Abstract
Background—: Essential hypertension has been recognized as a disease resulting from a combination of environmental and genetic factors. Recent studies demonstrated that microRNAs (miRNAs) are involved in cardiac hypertrophy and heart failure. However, little is known about the roles of miRNAs in essential hypertension. Methods and Results—: Using microarray-based miRNA expression profiling, we compared the miRNA expressions in plasma samples from 13 hypertensive patients and 5 healthy control subjects. Twenty-seven miRNAs were found to be differentially expressed. The expressions of selected miRNAs (miR-296–5p, let-7e, and a human cytomegalovirus [HCMV]–encoded miRNA, hcmv-miR-UL112) were validated independently in plasma samples from 24 hypertensive patients and 22 control subjects. The absolute expression levels of hcmv-miR-UL112, miR-296–5p, and let-7e were further determined in 127 patients and 67 control subjects (fold changes are 2.5, 0.5, and 1.7 respectively; all P <0.0001). Additionally, we demonstrated that interferon regulatory factor 1 is a direct target of hcmv-miR-UL112. Increased HCMV seropositivity and quantitative titers were found in the hypertension group compared with the control group (52.7% versus 30.9%, P =0.0005; 1870 versus 54 copies per 1 mL plasma, P <0.0001). Seropositivity, log-transformed copies of HCMV, and hcmv-miR-UL112 were independently associated with an increased risk of hypertension (odds ratio, 2.48; 95% confidence interval, 1.48 to 4.15; P =0.0005; odds ratio, 1.97; 95% confidence interval, 1.58 to 2.46; P <0.0001; and odds ratio, 2.55; 95% confidence interval, 1.98 to 3.27; P <0.0001, respectively). Conclusions—: We report for the first time a circulating miRNA profile for hypertensive patients and demonstrate a novel link between HCMV infection and essential hypertension. These findings may reveal important insights into the pathogenesis of essential hypertension. Clinical Trial Registration—: URL: http://www.clinicaltrials.gov . Unique identifier: NCT00420784.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
MicroRNA expression profiles classify human cancers
Lu, J., Getz, G., Miska, E. A., Alvarez-Saavedra, E., Lamb, J., Peck, D., Sweet-Cordero, A., Ebert, B. L., Mak, R. H., Ferrando, A. A., et al. (2005) · Nature · doi:10.1038/nature03702 · Cited by 9,539
Combinatorial microRNA target predictions
Krek, A., Grün, D., Poy, M. N., Wolf, R., Rosenberg, L., Epstein, E. J., MacMenamin, P., da Piedade, I., Gunsalus, K. C., Stoffel, M., et al. (2005) · Nature Genetics · doi:10.1038/ng1536 · Cited by 4,603
WRITING GROUP MEMBERS, Lloyd-Jones, D., Adams, R., Carnethon, M., De Simone, G., Ferguson, T. B., Flegal, K., Ford, E., Furie, K., Go, A., et al. (2009) · Circulation · doi:10.1161/circulationaha.108.191259 · Cited by 3,908
WRITING GROUP MEMBERS, Lloyd-Jones, D., Adams, R., Carnethon, M., De Simone, G., Ferguson, T. B., Flegal, K., Ford, E., Furie, K., Go, A., et al. (2009) · Circulation · doi:10.1161/circulationaha.108.191261 · Cited by 3,140
The microRNA.org resource: targets and expression
Betel, D., Wilson, M., Gabow, A., Marks, D. S., & Sander, C. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm995 · Cited by 2,503
Requirement of bic/microRNA-155 for Normal Immune Function
Rodriguez, A., Vigorito, E., Clare, S., Warren, M. V., Couttet, P., Soond, D. R., van Dongen, S., Grocock, R. J., Das, P. P., Miska, E. A., et al. (2007) · Science · doi:10.1126/science.1139253 · Cited by 1,833
IRF Family of Transcription Factors as Regulators of Host Defense
Taniguchi, T., Ogasawara, K., Takaoka, A., & Tanaka, N. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.623 · Cited by 1,658
Stark, A., Brennecke, J., Bushati, N., Russell, R. B., & Cohen, S. M. (2005) · Cell · doi:10.1016/j.cell.2005.11.023 · Cited by 1,080
Miyamoto, M., Fujita, T., Kimura, Y., Maruyama, M., Harada, H., Sudo, Y., Miyata, T., & Taniguchi, T. (1988) · Cell · doi:10.1016/s0092-8674(88)91307-4 · Cited by 978
Elevated blood pressures in mice lacking endothelial nitric oxide synthase
Shesely, E. G., Maeda, N., Kim, H.-S., Desai, K. M., Krege, J. H., Laubach, V. E., Sherman, P. A., Sessa, W. C., & Smithies, O. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.23.13176 · Cited by 914
Effects on blood pressure and exploratory behaviour of mice lacking angiotensin II type-2 receptor
Ichiki, T., Labosky, P. A., Shiota, C., Okuyama, S., Imagawa, Y., Fogo, A., Niimura, F., Ichikawa, I., Hogan, B. L. M., & lnagami, T. (1995) · Nature · doi:10.1038/377748a0 · Cited by 858
Potential Role of Human Cytomegalovirus and p53 Interaction in Coronary Restenosis
Speir, E., Modali, R., Huang, E.-S., Leon, M. B., Shawl, F., Finkel, T., & Epstein, S. E. (1994) · Science · doi:10.1126/science.8023160 · Cited by 753
Liew, C.-C., Ma, J., Tang, H.-C., Zheng, R., & Dempsey, A. A. (2006) · Journal of Laboratory and Clinical Medicine · doi:10.1016/j.lab.2005.10.005 · Cited by 660
Host Immune System Gene Targeting by a Viral miRNA
Stern-Ginossar, N., Elefant, N., Zimmermann, A., Wolf, D. G., Saleh, N., Biton, M., Horwitz, E., Prokocimer, Z., Prichard, M., Hahn, G., et al. (2007) · Science · doi:10.1126/science.1140956 · Cited by 645
Immunobiology of Human Cytomegalovirus: from Bench to Bedside
Crough, T., & Khanna, R. (2009) · Clinical Microbiology Reviews · doi:10.1128/cmr.00034-08 · Cited by 644
MicroRNAs Add a New Dimension to Cardiovascular Disease
Small, E. M., Frost, R. J. A., & Olson, E. N. (2010) · Circulation · doi:10.1161/circulationaha.109.889048 · Cited by 599
Prediction of both conserved and nonconserved microRNA targets in animals
Wang, X., & El Naqa, I. M. (2008) · Bioinformatics · doi:10.1093/bioinformatics/btm595 · Cited by 529
Endothelial nuclear factor-kappa B and the initiation of the atherosclerotic lesion.
Collins, T. (1993) · PubMed · Cited by 524
miR-296 Regulates Growth Factor Receptor Overexpression in Angiogenic Endothelial Cells
Würdinger, T., Tannous, B. A., Saydam, O., Skog, J., Grau, S., Soutschek, J., Weissleder, R., Breakefield, X. O., & Krichevsky, A. M. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.10.005 · Cited by 463
Zhou, Y. F., Leon, M. B., Waclawiw, M. A., Popma, J. J., Yu, Z. X., Finkel, T., & Epstein, S. E. (1996) · New England Journal of Medicine · doi:10.1056/nejm199608293350903 · Cited by 451
Diep, Q. N., El Mabrouk, M., Cohn, J. S., Endemann, D., Amiri, F., Virdis, A., Neves, M. F., & Schiffrin, E. L. (2002) · Circulation · doi:10.1161/01.cir.0000016049.86468.23 · Cited by 345
Nieto, F. J., Adam, E., Sorlie, P., Farzadegan, H., Melnick, J. L., Comstock, G. W., & Szklo, M. (1996) · Circulation · doi:10.1161/01.cir.94.5.922 · Cited by 303
Circulating MicroRNAs as Biomarkers and Potential Paracrine Mediators of Cardiovascular Disease
Gupta, S. K., Bang, C., & Thum, T. (2010) · Circulation: Cardiovascular Genetics · doi:10.1161/circgenetics.110.958363 · Cited by 292
Wang, X., Qian, R., Zhang, W., Chen, S., Jin, H., & Hu, R. (2009) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2008.05057.x · Cited by 271
Self-citationPrognostic Value of Different Indices of Blood Pressure Variability in Hypertensive Patients
Pierdomenico, S. D., Di Nicola, M., Esposito, A. L., Di Mascio, R., Ballone, E., Lapenna, D., & Cuccurullo, F. (2009) · American Journal of Hypertension · doi:10.1038/ajh.2009.103 · Cited by 264
Marques, F. Z., Campain, A. E., Tomaszewski, M., Zukowska-Szczechowska, E., Yang, Y. H. J., Charchar, F. J., & Morris, B. J. (2011) · Hypertension · doi:10.1161/hypertensionaha.111.180729 · Cited by 233
Spizzo, R., Nicoloso, M. S., Croce, C. M., & Calin, G. A. (2009) · Cell · doi:10.1016/j.cell.2009.04.040 · Cited by 232
Advances in microRNAs: implications for immunity and inflammatory diseases
Sonkoly, E., & Pivarcsi, A. (2009) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2008.00534.x · Cited by 183
Bellas, R. E., Lee, J. S., & Sonenshein, G. E. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118313 · Cited by 183
Vascular inflammation: a role in vascular disease in hypertension?
Virdis, A., & Schiffrin, E. L. (2003) · Current Opinion in Nephrology and Hypertension · doi:10.1097/00041552-200303000-00009 · Cited by 182
Speir, E., Yu, Z.-X., Ferrans, V. J., Huang, E.-S., & Epstein, S. E. (1998) · Circulation Research · doi:10.1161/01.res.83.2.210 · Cited by 167
Role of superoxide anions in the mediation of endothelium-dependent contractions.
Cosentino, F., Sill, J. C., & Katusić, Z. S. (1994) · Hypertension · doi:10.1161/01.hyp.23.2.229 · Cited by 165
Cytomegalovirus Infection Causes an Increase of Arterial Blood Pressure
Cheng, J., Ke, Q., Jin, Z., Wang, H., Kocher, O., Morgan, J. P., Zhang, J., & Crumpacker, C. S. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000427 · Cited by 163
Ceolotto, G., Papparella, I., Bortoluzzi, A., Strapazzon, G., Ragazzo, F., Bratti, P., Fabricio, A. S. C., Squarcina, E., Gion, M., Palatini, P., et al. (2010) · American Journal of Hypertension · doi:10.1038/ajh.2010.211 · Cited by 155
MicroRNAs as Novel Biomarkers for Breast Cancer
Heneghan, H., Miller, N., Lowery, A., Sweeney, K. J., & Kerin, M. J. (2009) · Journal of Oncology · doi:10.1155/2010/950201 · Cited by 153
Kowalik, T. F., Wing, B., Haskill, J. S., Azizkhan, J. C., Baldwin, A. S., & Huang, E. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.3.1107 · Cited by 150
Cytomegalovirus Infection Impairs the Nitric Oxide Synthase Pathway
Weis, M., Kledal, T. N., Lin, K. Y., Panchal, S. N., Gao, S., Valantine, H. A., Mocarski, E. S., & Cooke, J. P. (2004) · Circulation · doi:10.1161/01.cir.0000109692.16004.af · Cited by 149
Human Cytomegalovirus Secretome Contains Factors That Induce Angiogenesis and Wound Healing
Dumortier, J., Streblow, D. N., Moses, A. V., Jacobs, J. M., Kreklywich, C. N., Camp, D., Smith, R. D., Orloff, S. L., & Nelson, J. A. (2008) · Journal of Virology · doi:10.1128/jvi.00502-08 · Cited by 123
Bachmaier, K., Neu, N., Pummerer, C., Duncan, G. S., Mak, T. W., Matsuyama, T., & Penninger, J. M. (1997) · PubMed · Cited by 106
MicroRNAs in Cardiovascular Biology and Heart Disease
Catalucci, D., Gallo, P., & Condorelli, G. (2009) · Circulation Cardiovascular Genetics · doi:10.1161/circgenetics.109.857425 · Cited by 100
A truth serum for cancer — microRNAs have major potential as cancer biomarkers
Chin, L. J., & Slack, F. J. (2008) · Cell Research · doi:10.1038/cr.2008.290 · Cited by 93
Vecchione, C., Frati, A., Pardo, A. D., Cifelli, G., Carnevale, D., Gentile, M. T., Carangi, R., Landolfi, A., Carullo, P., Bettarini, U., et al. (2009) · Hypertension · doi:10.1161/hypertensionaha.108.128124 · Cited by 80
Goto, M., Mukoyama, M., Sugawara, A., Suganami, T., Kasahara, M., Yahata, K., Makino, H., Suga, S., Tanaka, I., & Nakao, K. (2002) · Hypertension Research · doi:10.1291/hypres.25.125 · Cited by 41
Priviero, F. B. M., Zemse, S. M., Teixeira, C. E. G., & Webb, R. C. (2009) · American Journal of Hypertension · doi:10.1038/ajh.2009.18 · Cited by 39
Cited by
Murray, D. D., Suzuki, K., Law, M., Trebicka, J., Neuhaus, J., Wentworth, D., Johnson, M., Vjecha, M. J., Kelleher, A. D., Emery, S., et al. (2015) · PLOS ONE · doi:10.1371/journal.pone.0139981 · Cited by 2,740
MicroRNAs in metabolism and metabolic disorders
Rottiers, V., & Näär, A. M. (2012) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3313 · Cited by 1,156
Circulating MicroRNAs: Novel Biomarkers and Extracellular Communicators in Cardiovascular Disease?
Creemers, E. E., Tijsen, A. J., & Pinto, Y. M. (2012) · Circulation Research · doi:10.1161/circresaha.111.247452 · Cited by 1,009
Methodological challenges in utilizing mi RNA s as circulating biomarkers
Moldovan, L., Batte, K. E., Trgovcich, J., Wisler, J., Marsh, C. B., & Piper, M. (2014) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12236 · Cited by 436
Wolf, T., Baier, S. R., & Zempleni, J. (2015) · The Journal of Nutrition · doi:10.3945/jn.115.218586 · Cited by 364
Metadata
- Authors
- Li, S., Zhu, J., Zhang, W., Chen, Y., Zhang, K., Popescu, L. M., Ma, X., Bond Lau, W., Rong, R., Yu, X., Wang, B., Li, Y., Xiao, C., Zhang, M., Wang, S., Yu, L., Chen, A. F., Yang, X., & Cai, J.
- Venue
- Circulation
- Published
- 2011-07-12
- Volume
- 124
- Issue
- 2
- Pages
- 175-184
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2050245631
- Cited by
- 333
- References
- 44
- FWCI
- 8.15
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.